argenx SE | ARGX - Equity Capital And Reserves


argenx SE reported $6.1B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.





Equity Capital And Reserves Change Date
AstraZeneca USD 48.67B 2.78B Dec/2025
Galapagos EUR 3.24B 788.91M Dec/2025
Genmab DKK 5.85B 96M Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
GRIFOLS EUR 5.29B 108.05M Dec/2025
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Qiagen NV USD 3.78B 128.73M Dec/2025
UCB EUR 10.87B 1.18B Dec/2025